These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26298608)

  • 21. Hereditary angioneurotic edema and Charcot-Marie-Tooth disease in the same family.
    Fernandez PG; Day JH; Simpson NE; Zachariah PK
    Can Med Assoc J; 1978 Sep; 119(5):455-8. PubMed ID: 688147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multiple phenotypic manifestations of X-linked spinobulbar muscular atrophy].
    Vandenberghe N; Bouhour F; Petiot P; Gonnaud PM; Latour P; Broussolle E; Vial C
    Rev Neurol (Paris); 2009 Jan; 165(1):31-7. PubMed ID: 18667219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family.
    Santoro L; Manganelli F; Di Maio L; Barbieri F; Carella M; D'Adamo P; Casari G
    Neuromuscul Disord; 2002 May; 12(4):399-404. PubMed ID: 12062259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutation in the periaxin gene causal to Charcot-Marie-Tooth disease type 4F.
    Chen YH; Zhang H; Meng LB; Tang XY; Gong T; Yin J
    J Int Med Res; 2020 Feb; 48(2):300060519862064. PubMed ID: 31426691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy.
    Hashizume A; Katsuno M; Banno H; Suzuki K; Suga N; Mano T; Atsuta N; Oe H; Watanabe H; Tanaka F; Sobue G
    Brain; 2012 Sep; 135(Pt 9):2838-48. PubMed ID: 22773541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chronic leg ulcer presenting with Charcot-Marie-Tooth disease and type 2 diabetes: a case report.
    Ren H; You C; Han C
    Int J Low Extrem Wounds; 2013 Mar; 12(1):30-4. PubMed ID: 23446367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A family with Charcot-Marie-Tooth disease and Leber's optic atrophy.
    McLeod JG; Low PA; Morgan JA
    Proc Aust Assoc Neurol; 1975; 12():23-5. PubMed ID: 1215391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic distal spinal amyotrophy or spinal forms of Charcot-Marie disease. A report on six sporadic adult cases (author's transl)].
    Serratrice G; Gastaut JL
    Rev Neurol (Paris); 1979; 135(11):815-26. PubMed ID: 555021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carbamazepine-sensitive neuromyotonia and Charcot-Marie-Tooth disease of the neuronal type].
    Serratrice G; Pouget J; Pellissier JF; Cros D
    Rev Neurol (Paris); 1989; 145(12):867-8. PubMed ID: 2694289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phenotypic heterogeneity in Japanese Charcot-Marie-Tooth disease type 1A patients with PMP-22 gene duplication].
    Yamamoto M; Sobue G; Yasuda T; Yamamoto K; Kumazawa K; Mitsuma T
    Rinsho Shinkeigaku; 1995 Oct; 35(10):1085-91. PubMed ID: 8821490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlates of Charcot-Marie-Tooth disease in patients with pes cavus deformities.
    Karakis I; Gregas M; Darras BT; Kang PB; Jones HR
    Muscle Nerve; 2013 Apr; 47(4):488-92. PubMed ID: 23460299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexistence of peripheral myelin protein 22 and dystrophin mutations in a chinese boy.
    Wang Z; Cui F; Chen D; Pu C; Chen Z; Yang F; Wu H; Huang X
    Muscle Nerve; 2013 Dec; 48(6):979-83. PubMed ID: 23740413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequencing analysis of the spinal bulbar muscular atrophy CAG expansion reveals absence of repeat interruptions.
    Fratta P; Collins T; Pemble S; Nethisinghe S; Devoy A; Giunti P; Sweeney MG; Hanna MG; Fisher EM
    Neurobiol Aging; 2014 Feb; 35(2):443.e1-3. PubMed ID: 24041967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal and bulbar muscular atrophy: pathogenesis and clinical management.
    Grunseich C; Rinaldi C; Fischbeck KH
    Oral Dis; 2014 Jan; 20(1):6-9. PubMed ID: 23656576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of Charcot-Marie-Tooth disease type 1A and anti-MAG neuropathy.
    Piscosquito G; Salsano E; Ciano C; Palamara L; Morbin M; Pareyson D
    J Peripher Nerv Syst; 2013 Jun; 18(2):185-8. PubMed ID: 23781967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autopsy case of a patient with Charcot-Marie-Tooth disease type 1A and suspected chronic inflammatory demyelinating polyradiculoneuropathy, which was later diagnosed as amyotrophic lateral sclerosis].
    Higuchi Y; Sakiyama Y; Nishihira Y; Endo K; Suwazono S; Suehara M
    Rinsho Shinkeigaku; 2012; 52(10):750-6. PubMed ID: 23064625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charcot-Marie-Tooth disease masquerading as acute demyelinating encephalomyelitis-like illness.
    Kim GH; Kim KM; Suh SI; Ki CS; Eun BL
    Pediatrics; 2014 Jul; 134(1):e270-3. PubMed ID: 24958582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The genetics of type 1 Charcot-Marie-Tooth disease, the hereditary focal neuropathies and the hereditary distal motor neuropathies].
    Sevilla T
    Rev Neurol; 2000 Jan 1-15; 30(1):71-9. PubMed ID: 10743001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.